Preclinical Alzheimer's disease and its outcome: A longitudinal cohort study

The Lancet Neurology

Volumn 12, Issue 10, 2013, Pages 957-965

  Vos, Stephanie JB ^a   Xiong, Chengjie ^b   Visser, Pieter Jelle ^a,c   Jasielec, Mateusz S ^b   Hassenstab, Jason ^b   Grant, Elizabeth A ^b   Cairns, Nigel J ^b   Morris, John C ^b   Holtzman, David M ^b   Fagan, Anne M ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; COHORT ANALYSIS; DEPTH PERCEPTION; DISEASE COURSE; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; LANGUAGE ABILITY; LONG TERM MEMORY; LONGITUDINAL STUDY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MORTALITY; NEUROFIBRILLARY TANGLE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; STAGING; SURVIVAL; WECHSLER MEMORY SCALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY, EPISODIC; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PREVALENCE; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TAU PROTEINS;

EID: 84884127276     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70194-7     Document Type: Article

References (37)

1. Price J, Morris JC Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999, 45:358-368.
2. Hulette C, Welsh-Bohmer K, Murray M, Saunders A, Mash D, Mcintyre L Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 1998, 57:1168-1174.
3. Braak H, Braak E Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997, 18:351-357.
4. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012, 367:795-804.
5. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 2011, 7:280-292.
6. Knopman DS, Jack CR, Wiste HJ, et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology 2012, 78:1576-1582.
7. Berg L, McKeel DW, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and ApoE genotype. Arch Neurol 1998, 55:326-335.
8. Morris JC The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
9. Johnson DK, Storandt M, Morris JC, Langford ZD, Galvin JE Cognitive profiles in dementia: Alzheimer disease versus nondemented aging. Neurology 2008, 71:1783-1789.
10. Berg L, Miller JP, Baty J, Rubin EH, Morris JC, Figiel G Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention. Ann Neurol 1992, 31:242-249.
11. Storandt M, Grant EA, Miller JP, Morris JC Longitudinal course and neuropathologic outcomes in original vs. revised MCI and in pre-MCI. Neurology 2006, 67:467-473.
12. Bondi MW, Jak AJ, Delano-Wood L, Jacobson MW, Delis DC, Salmon DP Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychol Rev 2008, 18:73-90.
13. Grober E, Buschke H, Crystal H, Bang S Screening for dementia by memory testing. Neurology 1988, 38:900-903.
14. Wechsler D Manual: Wechsler memory scale-revised 1987, Psychological Corporation, San Antonio, TX.
15. Johnson DK, Storandt M, Morris JC, Galvin JE Longitudinal study of the transition from healthy aging to Alzheimer's disease. Arch Neurol 2009, 66:1254-1259.
16. Jack CR, Knopman DS, Weigand SD, et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 2012, 71:765-775.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work-Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
18. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement 2011, 7:270-279.
19. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007, 6:734-746.
20. Cairns NJ, Taylor-Reinwald L, Morris JC Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. Alzheimers Dement 2010, 6:274-279. the Alzheimer's Disease Neuroimaging Initiative.
21. Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012, 123:1-11.
22. Castellano JM, Kim J, Stewart FR, et al. Human APOE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med 2011, 3:89ra57.
23. Fine J, Gray R A proportional hazards model for the subdistribution of a competing risk. J Amer Statist Assoc 1999, 94:496-509.
24. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL Analysis of longitudinal data 2002, Oxford University Press, New York. 2nd edn.
25. Akaike H A new look at the statistical model identification. IEEE Trans Automat Contr 1974, 19:716-723.
26. Lönnroos E, Kyyrönen P, Bell JS, van der Cammen TJ, Hartikainen S Risk of death among persons with Alzheimer's disease: a national register-based nested case-control study. J Alzheimers Dis 2013, 33:157-164.
27. Wallin AK, Blennow K, Zetterberg H, Londos E, Minthon L, Hansson O CSF biomarkers predict a more malignant outcome in Alzheimer disease. Neurology 2010, 74:1531-1537.
28. Lopponen M, Raiha I, Isoaho R, Vahlberg T, Puolijoki H, Kivela SL Dementia associates with undermedication of cardiovascular diseases in the elderly: a population-based study. Dement Geriatr Cogn Disord 2006, 22:132-141.
29. Wadley VG, Okonkwo O, Crowe M, et al. Mild cognitive impairment and everyday function: an investigation of driving performance. J Geriatr Psychiatry Neurol 2009, 22:87-94.
30. Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR Does Alzheimer's disease begin in the brainstem?. Neuropathol Appl Neurobiol 2009, 35:532-554.
31. Morris JC, Roe CM, Xiong C, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 2010, 67:122-131.
32. Desikan RS, McEvoy LK, Holland D, et al. Apolipoprotein E e{open}4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. Am J Neuroradiol 2013, 34:505-510.
33. Tarawneh R, D'Angelo G, Macy E, et al. Visinin-like protein 1: diagnostic and prognostic biomarker in Alzheimer's disease. Ann Neurol 2011, 70:274-285.
34. Acosta-Baena N, Sepulveda-Falla D, Lopera-Gomez GM, et al. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study. Lancet Neurol 2011, 10:213-220.
35. Villareal DT, Grant E, Miller JP, Strorandt M, McKeel DW, Morris JC Clinical outcomes of possible versus probable Alzheimer's disease. Neurology 2003, 61:661-667.
36. Vos S, van Rossum I, Burns L, et al. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging 2012, 33:2272-2281.
37. Han L, Cole M, Bellavance F, McCusker J, Primeau F Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis. Int Psychogeriatr 2000, 12:231-247.